Vaxcyte Inc’s filing revealed that its Officer Wassil Jim acquired Company’s shares for reported $0.71 million on Feb 03 ’25. In the deal valued at $88.20 per share,8,000 shares were bought.
Then, GUGGENHIME ANDREW sold 8,000 shares, generating $692,101 in total proceeds. Upon selling the shares at $86.51, the PRESIDENT AND CFO now owns 109,491 shares.
Before that, GUGGENHIME ANDREW bought 8,000 shares. Vaxcyte Inc shares valued at $688,480 were divested by the Officer at a price of $86.06 per share.
Goldman initiated its Vaxcyte Inc [PCVX] rating to a Buy in a research note published on December 20, 2024; the price target was $135. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. TD Cowen began covering PCVX with “an Outperform” recommendation on April 18, 2023. Needham maintained its rating on January 03, 2023. It rated PCVX as “a Buy”.
Price Performance Review of PCVX
On Monday, Vaxcyte Inc [NASDAQ:PCVX] saw its stock fall -3.97% to $84.81. Over the last five days, the stock has lost -6.71%. Vaxcyte Inc shares have risen nearly 3.60% since the year began. Nevertheless, the stocks have risen 18.75% over the past one year. While a 52-week high of $121.06 was reached on 01/28/25, a 52-week low of $58.10 was recorded on 01/14/25. SMA at 50 days reached $87.74, while 200 days put it at $87.31.
Levels Of Support And Resistance For PCVX Stock
The 24-hour chart illustrates a support level at 83.64, which if violated will result in even more drops to 82.47. On the upside, there is a resistance level at 87.09. A further resistance level may holdings at 89.37. The Relative Strength Index (RSI) on the 14-day chart is 45.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.38, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 55.14%. Stochastics %K at 66.71% indicates the stock is a holding.
How much short interest is there in Vaxcyte Inc?
A steep rise in short interest was recorded in Vaxcyte Inc stocks on 2025-01-15, growing by 1.89 million shares to a total of 14.49 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 12.6 million shares. There was a rise of 13.05%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 15, 2022 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $66 price target.
